OngoingEUCTR 2019-002259-40
Safety study of SEP-363856 in schizophrenia
This study is ongoing in Romania and in View results. It is testing SEP-363856 for schizophrenia.
SchizophreniaOther
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedEUCTR 2022-000439-22
Safety study of Efficacy, Safety, and Tolerability of Aticaprant 10 mg in Depression
This study is completed in Belgium, in Sweden, in Czech Republic, .... It is testing Efficacy, Safety, and Tolerability of Aticaprant 10 mg for Depression.
DepressionOther
OngoingEUCTR 2020-001424-34
SAGE-217 for depression
This study is ongoing in the United Kingdom and in View results. It is testing SAGE-217 for depression.
DepressionOther
OngoingEUCTR 2009-011594-33
A study of tetrabenazine as adjunctive therapy to risperidone in first-episode schizophrenia
This study is ongoing in Germany. It is testing tetrabenazine for schizophrenia.
SchizophreniaOther
OngoingEUCTR 2021-001337-40
BXCL501 for schizophrenia
This study is ongoing in Spain. It is testing BXCL501 for schizophrenia.
Bipolarity, SchizophreniaOther
CompletedNCT05693935
TV-44749 for schizophrenia
This study is completed in the United States, in Bulgaria, in China, .... It is testing TV-44749 for schizophrenia.
SchizophreniaOtherFrom 18 Years to 64 Years
CompletedEUCTR 2020-004653-69
A study of Adjunctive Troriluzole in Obsessive Compulsive Disorder
This study is completed in Netherlands, in Italy, and in Spain. It focuses on Mental health.
Mental healthOther
CompletedEUCTR 2021-003834-34
Safety study of efficacy, Safety, and Tolerability of Luvadaxistat in Schizophrenia
This study is completed in Czech Republic, in Spain, and in View results. It is testing efficacy, Safety, and Tolerability of Luvadaxistat for Schizophrenia.
SchizophreniaOther
OngoingEUCTR 2021-005992-38
Safety study of single subcutaneous MIJ821 injection in Depression
This study is ongoing in Spain, in Poland, and in View results. It is testing single subcutaneous MIJ821 injection for Depression.
DepressionOther
OngoingEUCTR 2022-000574-26
A Phase 2b study with an extension to determine the safety and efficacy of GH001 in people with treatment-resistant depression
This study is ongoing in Ireland, in Czech Republic, in Poland, .... It focuses on depression.
DepressionOther
CompletedNCT03066505
Treatment Efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) for ADHD
This study is completed in the United States. It is testing Treatment Efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) for ADHD.
ADHDOtherFrom 18 Years to 25 Years
OngoingEUCTR 2014-004937-15
A double-blinded, placebo and lorazepam-controlled, four-way crossover, Phase II study effects of single oral administration of BNC210 on brain activity changes captured...
This study is ongoing in the United Kingdom. It focuses on Anxiety.
AnxietyOther